Final exam select topics-nanotox Flashcards

1
Q

what 3 things define nano tox

A
  • research/technology 1D structures 1-100nm
  • unique properties and functions
  • control or manipulate on atomic scale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are 3 key properties of them

A
  • size shape structure (physical chemical)
  • surface charge or reactivity
  • dose metric
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are 3 main compositions of chemistry and geometry for NPs

A

polymetric, inorganic and hybrid (IDK)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why do NPs like to form aggreagates

A

because they are so tiny

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is zeta potential + what is the value usually and why

A

electric potential of outer surface of sphere (generally <30mV or >30mV to avoid agglomeration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what iis special about their surface area

A

its massive compared to volume or whatever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are 2 things that its surface reactivity is related to

A

high surface area and surface charge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is protein corona

A

protein adsorption layer forms on the surface of colloidal NPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is protein corona important for

A

interactions with living matter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what do we use for dosemetrics (4 examples)

A

s, SA, mass, diameter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what influences absorption

A

routs and size/shape/surface chemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what influences metabolism

A

unknown if NPs are metabolized, functional groups may be

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what influences excretion

A

the routes, and the size/shape/charge/hydrophobicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is distribution like for NPs

A

can reach systemic circulate and distribute and interact with

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what influences distribution in the body

A

flow or entrapment in lymph vessels, adhesion to capillary walls, extraversion and movement into tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what 3 things are key factors for distribution

A

size, surface modifications and portal of entry

17
Q

what does a small particle size do to diffusion assays

A

increases speed

18
Q

what does a small particle size do to sedimentation assays

A

decreases speed

19
Q

what is an issue of something that NPs can do in an assay

A

trigger agglomerates

20
Q

why is it bad that NPs can trigger agglomerates

A

bc you dont know if that is toxicity or just it naturally causing agglomeration

21
Q

what are 4 things that NPs can also do in bioassays

A
  • adsorb dyes
  • cell culture micronutrients
  • trigger immune response
  • adsorb LPS or endotoxins
22
Q

what are some things that influence possible toxicity

A

shape, size, charge, formulation

23
Q

what are 10 potential types of toxicity mechanisms

A
  • damage membrane
  • mess up ETC/ respiration
  • ROS
  • cell signalling
  • DNA and chromosomal damage
  • frusterated phagocytosis
  • release of toxic metal ions from nanoparticles
  • ion homeostasis
  • disrupt lysosomes
  • disrupt cytoskeleton
24
Q

what are 4 orders of studies to do

A
  • physiochemical characterize things for NP
  • cell free assays (solubility, ROS, reactivity, aggregation)
  • cellular assays (primary cells, cell lines, ex vivo)
  • in vivo assays
25
Q

what are some issues with gaps in knowledge

A
  • critical to get adequate NP characterization
  • appropriate dose metric for each nanoparticle
  • validation for interference with assay (does it cause agglomeration)